This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Propofol Versus Midazolam With Fentanyl for EGD Endomicroscopy

This study has been completed.
Information provided by:
Shandong University Identifier:
First received: January 21, 2010
Last updated: June 13, 2011
Last verified: December 2009
This trial aims to compare the endomicroscopic image quality and sedation efficacy of propofol or midazolam with fentanyl.

Condition Intervention
Gastritis Functional Dyspepsia Drug: propofol Drug: midazolam with fentanyl

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator)

Resource links provided by NLM:

Further study details as provided by Shandong University:

Primary Outcome Measures:
  • endomicroscopic image quality [ Time Frame: 3 months ]

Secondary Outcome Measures:
  • sedation efficacy outcomes,patient assessment,physician assessment [ Time Frame: 3 months ]

Estimated Enrollment: 104
Study Start Date: January 2010
Study Completion Date: May 2010
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
sedation using propofol
Drug: propofol
conscious sedation using propofol
Experimental: 2
sedation using midazolam with fentanyl
Drug: midazolam with fentanyl
conscious sedation using midazolam with fentanyl


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • outpatients attending endomicroscopy
  • able to give written informed consent

Exclusion Criteria:

  • GI tract malignancy
  • coagulopathy
  • acute upper digestive tract bleeding
  • pregnancy or breast feeding
  • allergy to fluorescein sodium
  • impaired renal function
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01053871

China, Shandong
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China
Sponsors and Collaborators
Shandong University
Study Director: Yanqing Li, PhD. MD. Department of Gastroenterology, Qilu Hospital, Shandong University
  More Information

Responsible Party: Li-Yanqing, Department of Gastroenterology, Qilu Hospital, Shandong University Identifier: NCT01053871     History of Changes
Other Study ID Numbers: 2009SDU-QILU-G08
Study First Received: January 21, 2010
Last Updated: June 13, 2011

Keywords provided by Shandong University:

Additional relevant MeSH terms:
Signs and Symptoms, Digestive
Signs and Symptoms
Gastrointestinal Diseases
Digestive System Diseases
Stomach Diseases
Hypnotics and Sedatives
Central Nervous System Depressants
Physiological Effects of Drugs
Anesthetics, Intravenous
Anesthetics, General
Analgesics, Opioid
Sensory System Agents
Peripheral Nervous System Agents
Adjuvants, Anesthesia
Anti-Anxiety Agents
Tranquilizing Agents
Psychotropic Drugs
GABA Modulators
GABA Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action processed this record on July 19, 2017